Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 451735, 9 pages
http://dx.doi.org/10.1155/2015/451735
Review Article

Syncytiotrophoblast Functions and Fetal Growth Restriction during Placental Malaria: Updates and Implication for Future Interventions

Department of Zoology, College of Natural and Applied Science, University of Dar es Salaam, P.O. Box 35064, Dar es Salaam, Tanzania

Received 23 June 2015; Revised 8 September 2015; Accepted 4 October 2015

Academic Editor: Louiza Belkacemi

Copyright © 2015 Winifrida B. Kidima. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. L. Guyatt and R. W. Snow, “Impact of malaria during pregnancy on low birth weight in Sub-Saharan Africa,” Clinical Microbiology Reviews, vol. 17, no. 4, pp. 760–769, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Militello, E. M. Pappalardo, S. Ermito, A. Dinatale, A. Cavaliere, and S. Carrara, “Obstetric management of IUGR,” Journal of Prenatal Medicine, vol. 3, no. 1, pp. 6–9, 2009. View at Google Scholar
  3. R. W. Steketee, B. L. Nahlen, M. E. Parise, and C. Menendez, “The burden of malaria in pregnancy in malaria-endemic areas,” The American Journal of Tropical Medicine and Hygiene, vol. 64, supplement, no. 1-2, pp. 28–35, 2001. View at Google Scholar · View at Scopus
  4. D. L. Christensen, A. Kapur, and I. C. Bygbjerg, “Physiological adaption to maternal malaria and other adverse exposure: low birth weight, functional capacity, and possible metabolic disease in adult life,” International Journal of Gynecology and Obstetrics, vol. 115, supplement 1, pp. S16–S19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Morrison, J. A. Duffield, B. S. Muhlhausler, S. Gentili, and I. C. McMillen, “Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity,” Pediatric Nephrology, vol. 25, no. 4, pp. 669–677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Gamain, A. R. Trimnell, C. Scheidig, A. Schert, L. H. Miller, and J. D. Smith, “Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites,” Journal of Infectious Diseases, vol. 191, no. 6, pp. 1010–1013, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. G. Beeson, S. J. Rogerson, B. M. Cooke et al., “Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria,” Nature Medicine, vol. 6, no. 1, pp. 86–90, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Fried and P. E. Duffy, “Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta,” Science, vol. 272, no. 5267, pp. 1502–1504, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. J. G. Beeson, S. J. Rogerson, and G. V. Brown, “Evaluating specific adhesion of Plasmodium falciparum-infected erythrocytes to immobilised hyaluronic acid with comparison to binding of mammalian cells,” International Journal for Parasitology, vol. 32, no. 10, pp. 1245–1252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Magistrado, A. Salanti, N. G. Tuikue Ndam et al., “VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes,” Journal of Infectious Diseases, vol. 198, no. 7, pp. 1071–1074, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. K. Viebig, E. Levin, S. Dechavanne et al., “Disruption of Var2CSA gene impairs placental malaria associated adhesion phenotype,” PLoS ONE, vol. 2, no. 9, article e910, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Salanti, M. Dahlbäck, L. Turner et al., “Evidence for the involvement of VAR2CSA in pregnancy-associated malaria,” Journal of Experimental Medicine, vol. 200, no. 9, pp. 1197–1203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Fried, G. J. Domingo, C. D. Gowda, T. K. Mutabingwa, and P. E. Duffy, “Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta,” Experimental Parasitology, vol. 113, no. 1, pp. 36–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Zhu, G. Krishnegowda, G. Li, and D. Channe Gowda, “Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1,” Experimental Parasitology, vol. 128, no. 3, pp. 205–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Parroche, F. N. Lauw, N. Goutagny et al., “Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 6, pp. 1919–1924, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Coban, Y. Igari, M. Yagi et al., “Immunogenicity of whole-parasite vaccines against Plasmodium falciparum Involves malarial hemozoin and host TLR9,” Cell Host and Microbe, vol. 7, no. 1, pp. 50–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Dostert, G. Guarda, J. F. Romero et al., “Malarial hemozoin is a Nalp3 inflammasome activating danger signal,” PLoS ONE, vol. 4, no. 8, article e6510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Fried, R. O. Muga, A. O. Misore, and P. E. Duffy, “Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes,” The Journal of Immunology, vol. 160, no. 5, pp. 2523–2530, 1998. View at Google Scholar · View at Scopus
  19. E. T. Abrams, H. Brown, S. W. Chensue et al., “Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated β chemokine expression,” Journal of Immunology, vol. 170, no. 5, pp. 2759–2764, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. L. Suguitan Jr., R. G. F. Leke, G. Fouda et al., “Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria,” Journal of Infectious Diseases, vol. 188, no. 7, pp. 1074–1082, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. L. Suguitan Jr., T. J. Cadigan, T. A. Nguyen et al., “Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon,” The American Journal of Tropical Medicine and Hygiene, vol. 69, no. 6, pp. 574–581, 2003. View at Google Scholar · View at Scopus
  22. S. J. Rogerson, H. C. Brown, E. Pollina et al., “Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women,” Infection and Immunity, vol. 71, no. 1, pp. 267–270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. N. Bulmer, F. N. Rasheed, N. Francis, L. Morrison, and B. M. Greenwood, “Placental malaria. I. Pathological classification,” Histopathology, vol. 22, no. 3, pp. 211–218, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Menendez, J. Ordi, M. R. Ismail et al., “The impact of placental malaria on gestational age and birth weight,” The Journal of Infectious Diseases, vol. 181, no. 5, pp. 1740–1745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. P. R. Walter, Y. Garin, and P. Blot, “Placental pathologic changes in malaria. A histologic and ultrastructural study,” American Journal of Pathology, vol. 109, no. 3, pp. 330–342, 1982. View at Google Scholar · View at Scopus
  26. M. R. Ismail, J. Ordi, C. Menendez et al., “Placental pathology in malaria: a histological, immunohistochemical, and quantitative study,” Human Pathology, vol. 31, no. 1, pp. 85–93, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Rogerson, E. Pollina, A. Getachew, E. Tadesse, V. M. Lema, and M. E. Molyneux, “Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes,” The American Journal of Tropical Medicine and Hygiene, vol. 68, no. 1, pp. 115–119, 2003. View at Google Scholar · View at Scopus
  28. E. T. Abrams, H. Brown, S. W. Chensue et al., “Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated β chemokine expression,” The Journal of Immunology, vol. 170, no. 5, pp. 2759–2764, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Ordi, C. Menendez, M. R. Ismail et al., “Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells,” Journal of Infectious Diseases, vol. 183, no. 7, pp. 1100–1107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. J. N. Bulmer, F. N. Rasheed, L. Morrison, N. Francis, and B. M. Greenwood, “Placental malaria. II. A semi-quantitative investigation of the pathological features,” Histopathology, vol. 22, no. 3, pp. 219–225, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. I. P. Crocker, O. M. Tanner, J. E. Myers, J. N. Bulmer, G. Walraven, and P. N. Baker, “Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta,” Placenta, vol. 25, no. 4, pp. 273–282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Chaikitgosiyakul, M. J. Rijken, A. Muehlenbachs et al., “A morphometric and histological study of placental malaria shows significant changes to villous architecture in both Plasmodium falciparum and Plasmodium vivax infection,” Malaria Journal, vol. 13, article 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. N. W. Lucchi, D. Sarr, S. O. Owino, S. M. Mwalimu, D. S. Peterson, and J. M. Moore, “Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells,” Placenta, vol. 32, no. 8, pp. 579–585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. N. W. Lucchi, D. S. Peterson, and J. M. Moore, “Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum,” Malaria Journal, vol. 7, article 42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. N. W. Lucchi, R. Koopman, D. S. Peterson, and J. M. Moore, “Plasmodium falciparum-infected red blood cells selected for binding to cultured syncytiotrophoblast bind to chondroitin sulfate A and induce tyrosine phosphorylation in the syncytiotrophoblast,” Placenta, vol. 27, no. 4-5, pp. 384–394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Aboagye-Mathiesen, F. D. Tth, P. M. Petersen, and P. Ebbesen, “Human trophoblast interferons: production, purification, and biochemical characterization,” Placenta, vol. 15, no. 1, pp. 315–329, 1994. View at Google Scholar
  37. V. M. Abrahams and G. Mor, “Toll-like receptors and their role in the trophoblast,” Placenta, vol. 26, no. 7, pp. 540–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Deng, F. Han, and C. Wu, “Expression and immune effect of toll-like receptor 4 in human trophoblast cells,” Journal of Huazhong University of Science and Technology: Medical Science, vol. 29, no. 3, pp. 359–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Komine-Aizawa, H. Majima, C. Yoshida-Noro, and S. Hayakawa, “Stimuli through Toll-like receptor (TLR) 3 and 9 affect human chorionic gonadotropin (hCG) production in a choriocarcinoma cell line,” Journal of Obstetrics and Gynaecology Research, vol. 34, no. 2, pp. 144–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Mulla, K. Myrtolli, J. Potter et al., “Uric acid induces trophoblast IL-1β production via the inflammasome: implications for the pathogenesis of preeclampsia,” American Journal of Reproductive Immunology, vol. 65, no. 6, pp. 542–548, 2015. View at Publisher · View at Google Scholar
  41. V. M. Abrahams, “Pattern recognition at the maternal-fetal interface,” Immunological Investigations, vol. 37, no. 5-6, pp. 427–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. V. M. Abrahams, P. B. Aldo, S. P. Murphy et al., “TLR6 modulates first trimester trophoblast responses to peptidoglycan,” Journal of Immunology, vol. 180, no. 9, pp. 6035–6043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. R. T. Gazzinelli, P. Kalantari, K. A. Fitzgerald, and D. T. Golenbock, “Innate sensing of malaria parasites,” Nature Reviews Immunology, vol. 14, no. 11, pp. 744–757, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. R. McGready, S. J. Lee, J. Wiladphaingern et al., “Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study,” The Lancet Infectious Diseases, vol. 12, no. 5, pp. 388–396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Chatterjee, L. E. Weaver, K. M. Doersch et al., “Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice,” PLoS ONE, vol. 7, no. 7, Article ID e41884, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. D. L. Economides and K. H. Nicolaides, “Blood glucose and oxygen tension levels in small-for-gestational-age fetuses,” American Journal of Obstetrics and Gynecology, vol. 160, no. 2, pp. 385–389, 1989. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Jansson, K. Ylvén, M. Wennergren, and T. L. Powell, “Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction,” Placenta, vol. 23, no. 5, pp. 392–399, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Boeuf, E. H. Aitken, U. Chandrasiri et al., “Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport,” PLoS Pathogens, vol. 9, no. 2, Article ID e1003153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Lager and T. L. Powell, “Regulation of nutrient transport across the placenta,” Journal of Pregnancy, vol. 2012, Article ID 179827, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. S. Cerdeira and S. A. Karumanchi, “Angiogenic factors in preeclampsia and related disorders,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 11, Article ID a006585, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. C. E. Powe, R. J. Levine, and S. A. Karumanchi, “Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease,” Circulation, vol. 123, no. 24, pp. 2856–2869, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Kappou, S. Sifakis, A. Konstantinidou, N. Papantoniou, and D. A. Spandidos, “Role of the angiopoietin/Tie system in pregnancy (Review),” Experimental and Therapeutic Medicine, vol. 9, no. 4, pp. 1091–1096, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. E. K. Dorman, C. E. Shulman, J. Kingdom et al., “Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria,” Ultrasound in Obstetrics and Gynecology, vol. 19, no. 2, pp. 165–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Todros, A. Sciarrone, E. Piccoli, C. Guiot, P. Kaufmann, and J. Kingdom, “Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction,” Obstetrics & Gynecology, vol. 93, no. 4, pp. 499–503, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. A. L. Conroy, K. L. Silver, K. Zhong et al., “Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria,” Cell Host and Microbe, vol. 13, no. 2, pp. 215–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Boeuf, A. Tan, C. Romagosa et al., “Placental hypoxia during placental malaria,” Journal of Infectious Diseases, vol. 197, no. 5, pp. 757–765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Neres, C. R. F. Marinho, L. A. Gonçalves, M. B. Catarino, and C. Penha-Gonçalves, “Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women,” PLoS ONE, vol. 3, no. 2, article e1608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. K. L. Silver, K. Zhong, R. G. F. Leke, D. W. Taylor, and K. C. Kain, “Dysregulation of angiopoietins is associated with placental malaria and low birth weight,” PLoS ONE, vol. 5, no. 3, Article ID e9481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Muehlenbachs, T. K. Mutabingwa, S. Edmonds, M. Fried, and P. E. Duffy, “Hypertension and maternal-fetal conflict during placental malaria,” PLoS Medicine, vol. 3, no. 11, article e446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. K. L. Silver, A. L. Conroy, R. G. F. Leke et al., “Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi—associations with placental malaria and fetal growth restriction,” PLoS ONE, vol. 6, no. 9, Article ID e24985, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. W. B. Kidima, Malaria associated changes in fetal syncytiotrophoblast function [Ph.D. dissertation], Department of Tropical Medicine Medical Microbiology and Pharmacology, University of Hawaii at Manoa, 2013.
  62. A. L. Fowden, “The insulin-like growth factors and feto-placental growth,” Placenta, vol. 24, no. 8-9, pp. 803–812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton, “Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus,” Endocrine Reviews, vol. 27, no. 2, pp. 141–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. K. A. Woods, C. Camacho-Hübner, M. O. Savage, and A. J. L. Clark, “Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene,” The New England Journal of Medicine, vol. 335, no. 18, pp. 1363–1367, 1996. View at Publisher · View at Google Scholar
  65. M. M. H. Lau, C. E. H. Stewart, Z. Liu, H. Bhatt, P. Rotwein, and C. L. Stewart, “Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality,” Genes & Development, vol. 8, no. 24, pp. 2953–2963, 1994. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Laviola, S. Perrini, G. Belsanti et al., “Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling,” Endocrinology, vol. 146, no. 3, pp. 1498–1505, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Chiesa, J. F. Osborn, C. Haass et al., “Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry?” Clinical Chemistry, vol. 54, no. 3, pp. 550–558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. A. J. Umbers, P. Boeuf, C. Clapham et al., “Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation,” Journal of Infectious Diseases, vol. 203, no. 4, pp. 561–569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Laplante and D. M. Sabatini, “mTOR signaling at a glance,” Journal of Cell Science, vol. 122, no. 20, pp. 3589–3594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Huang, C. C. Dibble, M. Matsuzaki, and B. D. Manning, “The TSC1-TSC2 complex is required for proper activation of mTOR complex 2,” Molecular and Cellular Biology, vol. 28, no. 12, pp. 4104–4115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. J. D. Powell, K. N. Pollizzi, E. B. Heikamp, and M. R. Horton, “Regulation of immune responses by mTOR,” Annual Review of Immunology, vol. 30, pp. 39–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Wullschleger, R. Loewith, and M. N. Hall, “TOR signaling in growth and metabolism,” Cell, vol. 124, no. 3, pp. 471–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. D. A. Guertin and D. M. Sabatini, “Defining the role of mTOR in cancer,” Cancer Cell, vol. 12, no. 1, pp. 9–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Laplante and D. M. Sabatini, “MTOR signaling in growth control and disease,” Cell, vol. 149, no. 2, pp. 274–293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Dobashi, Y. Watanabe, C. Miwa, S. Suzuki, and S. Koyama, “Mammalian target of rapamycin: a central node of complex signaling cascades,” International Journal of Clinical and Experimental Pathology, vol. 4, no. 5, pp. 476–495, 2011. View at Google Scholar · View at Scopus
  76. S. Roos, T. L. Powell, and T. Jansson, “Placental mTOR links maternal nutrient availability to fetal growth,” Biochemical Society Transactions, vol. 37, no. 1, pp. 295–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Roos, O. Lagerlöf, M. Wennergren, T. L. Powell, and T. Jansson, “Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling,” American Journal of Physiology—Cell Physiology, vol. 297, no. 3, pp. C723–C731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. C. M. Scifres and D. M. Nelson, “Intrauterine growth restriction, human placental development and trophoblast cell death,” Journal of Physiology, vol. 587, no. 14, pp. 3453–3458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Roos, Y. Kanai, P. D. Prasad, T. L. Powell, and T. Jansson, “Regulation of placental amino acid transporter activity by mammalian target of rapamycin,” American Journal of Physiology: Cell Physiology, vol. 296, no. 1, pp. C142–C150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Roos, O. Lagerlöf, M. Wennergren, T. L. Powell, and T. Jansson, “Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling,” The American Journal of Physiology—Cell Physiology, vol. 297, no. 3, pp. C723–C731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Roos, N. Jansson, I. Palmberg, K. Säljö, T. L. Powell, and T. Jansson, “Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth,” The Journal of Physiology, vol. 582, no. 1, pp. 449–459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. E. B. Gordon, G. T. Hart, T. M. Tran et al., “Inhibiting the Mammalian target of rapamycin blocks the development of experimental cerebral malaria,” mBio, vol. 6, no. 3, pp. 1–17, 2015. View at Publisher · View at Google Scholar
  83. F. I. Onditi, O. W. Nyamongo, C. O. Omwandho et al., “Parasite accumulation in placenta of non-immune baboons during Plasmodium knowlesi infection,” Malaria Journal, vol. 14, article 118, 2015. View at Publisher · View at Google Scholar
  84. G. Dimasuay, T. Jansson, J. Glazier, S. Rogerson, and P. Boeuf, “Placental mTOR signaling and fetal growth restriction in placental malaria (#132),” in Proceedings of the Lorne Infection and Immunity Conference, Lorne, Australia, February 2014.
  85. R. Chen, Y. Zou, D. Mao et al., “The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation,” The Journal of Cell Biology, vol. 206, no. 2, pp. 173–182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. S. H. Landis, V. Lokomba, C. V. Ananth et al., “Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo,” Epidemiology & Infection, vol. 137, no. 2, pp. 294–304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. J. B. Griffin, V. Lokomba, S. H. Landis et al., “Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study,” Malaria Journal, vol. 11, no. 1, article 319, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. Aiko, D. J. Askew, S. Aramaki et al., “Differential levels of amino acid transporters system L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR,” BMC Pregnancy and Childbirth, vol. 14, no. 1, article 181, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Roos, T. L. Powell, and T. Jansson, “Placental mTOR links maternal nutrient availability to fetal growth,” Biochemical Society Transactions, vol. 37, no. 1, pp. 295–298, 2009. View at Publisher · View at Google Scholar · View at Scopus